Testing for long-term viral infection in advanced cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks for lasting viral infection in women with advanced cervical cancer. The goal is to better understand how the virus behaves and may help choose future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have cervical cancer that has spread beyond the cervix (stage IIIA to IVA).
- You must be at least 21 years old.
- Your kidneys and liver need to be working well enough for the tests in this study.
- You cannot be pregnant or breastfeeding.
- You should not have serious heart or lung problems, or a severe mental health condition that would interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture can boost your immune system's ability to fight cervical cancer, especially when the cancer has spread or come back. If you join, you'll receive acupuncture alongside your usual care, and researchers will monitor how your immune cells respond.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study tests whether adding immunotherapy to chemotherapy, then giving chemotherapy together with radiation, works better for advanced cervical cancer. It aims to improve cancer control and help people live longer, without major safety issues.
This study looks at whether simple blood tests can help predict how well first-line treatment works for cervical cancer that has come back or spread. It aims to improve future care by tracking changes in the blood over time.
This study tests whether electroacupuncture (a type of acupuncture using mild electric pulses) can help improve memory and thinking problems that many cancer survivors face. If it works, the goal is to make it part of standard cancer care.
This study tests whether adding electro-acupuncture (a gentle type of acupuncture with mild electrical pulses) to standard first-line immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. It aims to see if this combination improves quality of life and overall treatment outcomes.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.